# AVIR (Atea Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Atea Pharmaceuticals, Inc. reported $200.7M in total assets and a net loss of $155.4M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/AVIR
- Markdown: https://convexityos.com/fundamentals/AVIR.md
- SEC CIK: 0001593899
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:39 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001593899&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$172.1M | Operating profit |
| Net Income | FY 2025 | -$155.4M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.94 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $191.2M | Total debt: $213K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | $351.4M | $48.63M | -- | -- |
| Research & Development | $148.0M | $144.1M | $114.2M | $81.94M | $167.2M | $38.02M | $10.17M | $6.67M |
| Total Operating Expenses | $180.9M | $192.9M | $164.2M | $130.7M | $213.0M | $59.66M | $14.61M | $9.48M |
| **Operating Income** | -$180.9M | -$192.9M | -$164.2M | -$130.7M | $138.4M | -$11.03M | -$14.61M | -$9.48M |
| **EBITDA** | -$180.5M | -$192.5M | -$163.7M | -$130.4M | $138.4M | -$11.01M | -$14.59M | -$9.46M |
| Income Before Tax | -$164.5M | -$167.5M | -$134.9M | -$119.5M | $138.6M | -$10.95M | -$14.03M | -- |
| Income Tax Expense | -$6.16M | $925K | $1.02M | -$3.59M | $17.40M | -- | -- | -- |
| **Net Income** | -$158.3M | -$168.4M | -$136.0M | -$115.9M | $121.2M | -$10.95M | -$14.03M | -$9.06M |
| Basic EPS | -$1.94 | -$2.00 | -$1.63 | -$1.39 | $1.46 | -$0.51 | -$1.39 | -$0.90 |
| **Diluted EPS** | -$1.94 | -$2.00 | -$1.63 | -$1.39 | $1.37 | -$0.51 | -$1.39 | -$0.90 |
| Basic Shares Outstanding | 81.5M | 84.3M | 83.4M | 83.2M | 82.8M | 21.6M | 10.1M | 10.0M |
| Diluted Shares Outstanding | 81.5M | 84.3M | 83.4M | 83.2M | 88.2M | 21.6M | 10.1M | 10.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $27.09M | $28.15M | $41.13M | $47.82M | $38.35M | $32.27M | $29.58M | $25.67M |
| Total Operating Expenses | $34.01M | $35.10M | $48.01M | $54.93M | $45.57M | $41.34M | $39.04M | $39.03M |
| **Operating Income** | -$34.01M | -$35.10M | -$48.01M | -$54.93M | -$45.57M | -$41.34M | -$39.04M | -$39.03M |
| **EBITDA** | -$33.91M | -$34.99M | -$47.90M | -$54.83M | -$45.46M | -$41.24M | -$38.94M | -$38.92M |
| Income Before Tax | -$32.12M | -$32.91M | -$45.39M | -$51.63M | -$41.85M | -$36.95M | -$34.07M | -$33.32M |
| Income Tax Expense | $38K | $24K | $50K | -$6.77M | $196K | $207K | $203K | $225K |
| **Net Income** | -$32.16M | -$32.93M | -$45.44M | -$44.87M | -$42.05M | -$37.16M | -$34.27M | -$33.54M |
| Basic EPS | -$0.40 | -$0.41 | -$0.57 | -- | -$0.53 | -$0.44 | -$0.40 | -- |
| **Diluted EPS** | -$0.40 | -$0.41 | -$0.57 | -- | -$0.53 | -$0.44 | -$0.40 | -- |
| Basic Shares Outstanding | 80.2M | 80.1M | 79.2M | -- | 79.1M | 83.7M | 85.2M | -- |
| Diluted Shares Outstanding | 80.2M | 80.1M | 79.2M | -- | 79.1M | 83.7M | 85.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $95.71M | $64.70M | $143.8M | $188.5M | $764.4M | $850.1M | $21.66M |
| Short-Term Investments | $206.1M | $390.0M | $434.3M | $458.2M | -- | -- | -- |
| **Cash & Short-Term Investments** | $301.8M | $454.7M | $578.1M | $646.7M | $764.4M | $850.1M | $21.66M |
| **Total Current Assets** | $311.0M | $462.4M | $590.5M | $660.9M | $772.4M | $863.5M | $21.91M |
| Property, Plant & Equipment, Net | $457K | $873K | $1.29M | $1.71M | $23K | $48K | $41K |
| Long-Term Investments | -- | $0 | $0 | $0 | -- | -- | -- |
| Other Non-Current Assets | $3.14M | $197K | $1.40M | $1.49M | $466K | $107K | $122K |
| **Total Non-Current Assets** | $4.23M | $2.31M | $4.51M | $5.79M | $489K | $155K | $163K |
| **Total Assets** | $315.2M | $464.7M | $595.0M | $666.7M | $772.9M | $863.6M | $22.07M |
| Accounts Payable | $12.95M | $4.46M | $4.25M | $2.55M | $4.53M | $60K | $548K |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $301.4M | -- |
| **Total Current Liabilities** | $39.78M | $18.60M | $32.38M | $18.48M | $56.88M | $315.8M | $2.44M |
| Other Non-Current Liabilities | -- | -- | -- | -- | $5.93M | $36K | $95K |
| **Total Non-Current Liabilities** | $0 | $7.20M | $7.40M | $7.66M | $5.93M | $36K | $95K |
| **Total Liabilities** | $39.78M | $25.80M | $39.78M | $26.14M | $62.81M | $315.8M | $2.53M |
| **Total Debt (incl. Leases)** | $843K | $1.64M | $2.40M | $3.12M | $197K | -- | -- |
| Common Stock | $78K | $84K | $83K | $83K | $83K | $82K | $10K |
| Retained Earnings | -$522.6M | -$364.2M | -$195.8M | -$59.88M | $56.03M | -$65.16M | -$54.21M |
| Accumulated Other Comp. Income | $174K | $233K | $207K | -$684K | -- | -- | -- |
| **Total Stockholders' Equity** | $275.4M | $438.9M | $555.2M | $640.6M | $710.1M | $547.8M | -$49.57M |
| Total Equity | $275.4M | $438.9M | $555.2M | $640.6M | $710.1M | $547.8M | -$49.57M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $97.92M | $76.55M | $79.32M | $95.71M | $77.34M | $87.72M | $119.4M | $64.70M |
| Short-Term Investments | $93.28M | $142.9M | $176.7M | $206.1M | $252.0M | $292.0M | $306.0M | $390.0M |
| **Cash & Short-Term Investments** | $191.2M | $219.5M | $256.0M | $301.8M | $329.3M | $379.7M | $425.4M | $454.7M |
| **Total Current Assets** | $200.3M | $228.7M | $263.2M | $311.0M | $336.1M | $385.6M | $433.7M | $462.4M |
| Property, Plant & Equipment, Net | $145K | $249K | $353K | $457K | $561K | $665K | $769K | $873K |
| Long-Term Investments | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $132K | $3.05M | $3.05M | $3.14M | $5.47M | $4.39M | $4.39M | $197K |
| **Total Non-Current Assets** | $438K | $3.62M | $3.88M | $4.23M | $6.83M | $6.00M | $6.26M | $2.31M |
| **Total Assets** | $200.7M | $232.3M | $267.1M | $315.2M | $343.0M | $391.6M | $440.0M | $464.7M |
| Accounts Payable | $4.84M | $10.06M | $9.45M | $12.95M | $3.52M | $8.84M | $7.39M | $4.46M |
| **Total Current Liabilities** | $25.02M | $28.12M | $33.37M | $39.78M | $20.18M | $20.12M | $21.75M | $18.60M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $7.01M | $7.07M | $7.13M | $7.20M |
| **Total Liabilities** | $25.02M | $28.12M | $33.37M | $39.78M | $27.18M | $27.19M | $28.88M | $25.80M |
| **Total Debt (incl. Leases)** | $213K | $424K | $634K | $843K | $1.04M | $1.25M | $1.45M | $1.64M |
| Common Stock | $80K | $80K | $80K | $78K | $78K | $81K | $85K | $84K |
| Retained Earnings | -$633.1M | -$600.9M | -$568.0M | -$522.6M | -$477.7M | -$435.7M | -$398.5M | -$364.2M |
| Accumulated Other Comp. Income | -$73K | -$96K | -$97K | $174K | $238K | $37K | $118K | $233K |
| **Total Stockholders' Equity** | $175.7M | $204.2M | $233.7M | $275.4M | $315.8M | $364.4M | $411.1M | $438.9M |
| Total Equity | $175.7M | $204.2M | $233.7M | $275.4M | $315.8M | $364.4M | $411.1M | $438.9M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$158.3M | -$168.4M | -$136.0M | -$115.9M | $121.2M | -$10.95M | -$14.03M | -$9.06M |
| Depreciation & Amortization | $416K | $416K | $416K | $260K | $29K | $19K | $17K | $17K |
| Stock-Based Compensation | $20.72M | $51.77M | $49.43M | $46.72M | $39.62M | $7.46M | $624K | $414K |
| Change in Receivables | -- | -- | -- | -- | -- | -$5.82M | -- | -- |
| Change in Payables | $8.49M | $206K | $1.70M | -$1.98M | $10.29M | -$488K | $157K | -$90K |
| **Operating Cash Flow** | -$132.0M | -$135.5M | -$85.39M | -$121.0M | -$87.00M | $296.7M | -$12.83M | -$7.91M |
| Capital Expenditure | -- | -- | -- | -$1.94M | -$4.0K | -$26K | -$2.0K | -$12K |
| **Free Cash Flow** | -- | -- | -- | -$122.9M | -$87.01M | $296.7M | -$12.83M | -$7.92M |
| Purchases of Investments | -$281.9M | -$461.2M | -$562.4M | -$545.4M | -- | -- | -- | -- |
| **Investing Cash Flow** | $188.8M | $56.10M | $40.30M | -$455.4M | -$4.0K | -$26K | -$2.0K | -$12K |
| Common Stock Issued | -- | -- | -- | -- | $1.47M | $27K | -- | $124K |
| Share Repurchases | -$25.52M | $0 | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | -$25.75M | $267K | $257K | $370K | $1.47M | $531.7M | -- | $27.48M |
| **Net Change in Cash** | $31.02M | -$79.13M | -$44.84M | -$576.0M | -$85.54M | $828.5M | -$12.83M | $19.56M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$32.16M | -$32.93M | -$45.44M | -$44.87M | -$42.05M | -$37.16M | -$34.27M | -$33.54M |
| Depreciation & Amortization | $104K | $104K | $104K | $104K | $104K | $104K | $104K | $104K |
| Stock-Based Compensation | $3.47M | $3.38M | $3.73M | $4.58M | $4.52M | $4.67M | $6.95M | $14.30M |
| Change in Payables | -$5.21M | $612K | -$3.50M | $9.43M | -$5.33M | $1.46M | $2.93M | -$1.33M |
| **Operating Cash Flow** | -$28.87M | -$37.08M | -$46.39M | -$28.22M | -$40.38M | -$32.87M | -$30.56M | -$30.40M |
| Purchases of Investments | -$11.97M | -$33.81M | -$74.55M | -$43.79M | -$14.78M | -$100.7M | -$122.6M | -$58.48M |
| **Investing Cash Flow** | $50.05M | $34.31M | $29.74M | $46.59M | $41.30M | $15.29M | $85.61M | -$3.37M |
| **Financing Cash Flow** | $195K | $0 | $257K | $0 | -$11.30M | -$14.09M | -$347K | $0 |
| **Net Change in Cash** | $21.37M | -$2.77M | -$16.40M | $18.37M | -$10.38M | -$31.67M | $54.70M | -$33.77M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | 39.4% | -22.7% | -- | -- |
| **Net Profit Margin** | -- | -- | -- | -- | 34.5% | -22.5% | -- | -- |
| Return on Equity (ROE) | -57.5% | -38.4% | -24.5% | -18.1% | 17.1% | -2.0% | -- | -- |
| Return on Assets (ROA) | -50.2% | -36.2% | -22.9% | -17.4% | 15.7% | -1.3% | -63.6% | -- |
| Current Ratio | 7.82x | 24.85x | 18.24x | 35.77x | 13.58x | 2.73x | 9.00x | -- |
| Quick Ratio | 7.59x | 24.44x | 17.86x | 35.00x | 13.44x | 2.69x | 8.90x | -- |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | +622.5% | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -194.4% | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -195.6% | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -195.2% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -129.3% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -129.3% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -88.5% | -81.0% | -72.5% | -57.5% | -46.6% | -37.4% | -33.9% | -38.4% |
| Return on Assets (ROA) | -77.4% | -71.2% | -63.5% | -50.2% | -42.9% | -34.8% | -31.7% | -36.2% |
| Current Ratio | 8.00x | 8.13x | 7.89x | 7.82x | 16.66x | 19.17x | 19.94x | 24.85x |
| Quick Ratio | 7.64x | 7.80x | 7.67x | 7.59x | 16.32x | 18.87x | 19.56x | 24.44x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
